NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in NovaBridge Biosciences as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −9 vs. Q2 2024
- Shares held
- 14.2M
- −938.9K (−6.2%) vs. Q2 2024
- Total value
- $17.6M
- −$7.72M (−30.5%) vs. Q2 2024
- New holders
- 4
- 5 more added
- Sold out
- 13
- 6 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 49 | $48.1M |
| Q1 2026 | 48 | $72.1M |
| Q4 2025 | 57 | $132.1M |
| Q3 2025 | 42 | $112.3M |
| Q2 2025 | 32 | $22.7M |
| Q1 2025 | 29 | $7.41M |
| Q4 2024 | 28 | $10.1M |
| Q3 2024 | 28 | $17.6M |
| Q2 2024 | 38 | $25.3M |
| Q1 2024 | 39 | $22.7M |
| Q4 2023 | 44 | $23.5M |
| Q3 2023 | 47 | $20.1M |
| Q2 2023 | 48 | $55.9M |
| Q1 2023 | 53 | $71.6M |
| Q4 2022 | 69 | $103.9M |
| Q3 2022 | 75 | $123.3M |
| Q2 2022 | 97 | $430.3M |
| Q1 2022 | 120 | $654.5M |
| Q4 2021 | 132 | $1.85B |
| Q3 2021 | 145 | $2.61B |
| Q2 2021 | 136 | $2.38B |
| Q1 2021 | 80 | $1.13B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding NovaBridge Biosciences; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 417 | $0 | 0.00% | +417 | New |
| Citigroup Inc | 50 | $62 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 568 | $703 | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,191 | $1.47K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 1,367 | $1.69K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,438 | $1.78K | 0.00% | +1,438 | New |
| Tower Research Capital LLC (TRC) | 4,015 | $4.98K | 0.00% | +4,015 | New |
| Freestone Capital Holdings, LLC | 10,000 | $12.4K | 0.00% | +10,000 | New |
| Goldman Sachs Group Inc | 10,685 | $13.2K | 0.00% | −5,065−32.2% | Reduced |
| Millennium Management LLC | 11,325 | $14.0K | 0.00% | −28,983−71.9% | Reduced |
| Susquehanna International Group, LLP | 13,351 | $16.6K | 0.00% | −17,715−57.0% | Reduced |
| Geode Capital Management, LLC | 22,037 | $27.3K | 0.00% | −12,310−35.8% | Reduced |
| Barclays PLC | 30,370 | $37.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 30,647 | $38.0K | 0.00% | +16,767+120.8% | Added |
| Mariner, LLC | 31,535 | $39.1K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 43,039 | $53.4K | 0.00% | +25,163+140.8% | Added |
| Dimensional Fund Advisors LP | 58,358 | $72.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 63,800 | $79.1K | 0.00% | 00.0% | Unchanged |
| Alberta Investment Management Corp | 74,723 | $92.7K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 98,389 | $122.0K | 0.00% | +59,681+154.2% | Added |
| Standard Life Aberdeen plc | 162,580 | $201.6K | 0.00% | 00.0% | Unchanged |
| EDBI Pte Ltd | 222,136 | $275.4K | 0.37% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 408,519 | $506.6K | 0.00% | −69,923−14.6% | Reduced |
| Two Sigma Advisers, LP | 499,300 | $619.1K | 0.00% | −77,300−13.4% | Reduced |
| Temasek Holdings (Private) Ltd | 566,650 | $702.6K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 1,419,080 | $1.76M | 0.06% | +39,728+2.9% | Added |
| Caligan Partners LP | 3,499,330 | $4.34M | 1.38% | +124,539+3.7% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 6,909,220 | $8.57M | 0.19% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −272,193−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −271,400−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −244,875−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −102,961−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −57,933−100.0% | Sold out |
| Donald L. Hagan, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −14,064−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −12,514−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,565−100.0% | Sold out |
| Frazier Financial Advisors, LLC | 0 | $0 | 0.00% | −515−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |